Advanced search
Publication Cover
Journal of Drug Assessment Volume 8, 2019 - Issue 1
Journal homepage
1,513
Views
8
CrossRef citations to date
0
Altmetric
Oncology

An indirect treatment comparison of the efficacy of pembrolizumab versus competing regimens for the adjuvant treatment of stage III melanoma

Maria LorenziPrecision Xtract, Oakland, CA, USA;
,
Stella ArndorferPrecision Xtract, Oakland, CA, USA;
,
Raquel Aguiar-IbañezMerck & Co., Inc, Kenilworth, NJ, USA
,
Emilie ScherrerMerck & Co., Inc, Kenilworth, NJ, USACorrespondence[email protected]
,
Frank Xiaoqing LiuMerck & Co., Inc, Kenilworth, NJ, USA
&
Clemens KreplerMerck & Co., Inc, Kenilworth, NJ, USA
Pages 135-145 | Received 22 Mar 2019, Accepted 10 Jul 2019, Published online: 15 Aug 2019

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.